One of the newest medications being studied for use in treatment of primary amyloidosis is bortezomib, reports the Cleveland Clinic. The drug may help to improve some patient's outcomes.Continue Reading
Amyloidosis has three types: primary, familial and secondary, states Boston University. The major treatment for familial amyloidosis is liver transplant. The treatment for secondary amyloidosis depends on the underlying disease or infection. The standard treatment for primary amyloidosis has been chemotherapy for years. However, bortezomib is among a new class of drugs being considered for use in conjunction with chemotherapy.
Details of new and ongoing clinical trials for treatments of primary, familial, and secondary amyloidosis are available via the official websites for the amyloidosis centers at Boston University or the Mayo Clinic, two hospitals that treat and research this disease.Learn more about Conditions & Diseases